Invention Grant
- Patent Title: Sustained-release donepezil formulation
-
Application No.: US13036010Application Date: 2011-02-28
-
Publication No.: US09757338B2Publication Date: 2017-09-12
- Inventor: Adel Penhasi , Mila Gomberg
- Applicant: Adel Penhasi , Mila Gomberg
- Applicant Address: IL Or Akiva
- Assignee: Dexcel Pharma Technologies Ltd.
- Current Assignee: Dexcel Pharma Technologies Ltd.
- Current Assignee Address: IL Or Akiva
- Agency: Roach Brown McCarthy & Gruber, P.C.
- Agent Kevin D McCarthy
- Main IPC: A61K9/20
- IPC: A61K9/20 ; A61K9/28 ; A61K31/445 ; A61K47/38 ; A61K9/16 ; A61K47/32 ; A61K47/34
Abstract:
A sustained-release formulation for an acetylcholinesterase inhibitor, comprising an acetylcholinesterase inhibitor and at least two gel-forming polymers, and methods of manufacture thereof. The acetylcholinesterase inhibitor preferably comprises donepezil.
Public/Granted literature
- US20110237623A1 SUSTAINED-RELEASE DONEPEZIL FORMULATION Public/Granted day:2011-09-29
Information query
